Introduction {#s1}
============

*Phytophthora infestans* is a notorious oomycete pathogen, as the causal agent of potato late blight, which triggered the Great Irish Famine in the mid-nineteenth century (Pearson, [@B57]). Potato late blight is the most serious threat to potato plants and causes significant economic losses worldwide (Haverkort et al., [@B34]). In recent decades, several chemical fungicides have been developed and applied for controlling potato late blight by targeting the typical mechanisms of impairing the respiratory chain, disrupting metabolic homeostasis and inhibiting RNA polymerase of *P. infestans* (Matheron and Porchas, [@B49]; Mitani et al., [@B51]; Gullino et al., [@B31]). However, the highly complex and huge genome of *P. infestans* confers this pathogen the capacity of rapid evolution to overcome these chemical fungicides by altering a single gene (Haas et al., [@B33]). Moreover, it is important that the environmental, health and safety concerns associated with the chemical fungicides be taken into consideration. Thus, the need to develop alternatives to fungicide-based approaches that offers less toxicity, more target-specific and environmental-sustainability is desired and preferred.

Melatonin, a natural product also referred as N-acetyl-5-methoxytryptamine, is widely present in animals, plants, and microbes (Arendt, [@B5]; Pandi-Perumal et al., [@B56]; Reiter et al., [@B63]). Initially, its function is known to regulate circadian rhythms. Subsequently, other functions including the modulation of mood, sleep, metabolism, and antioxidant are also established in diverse organisms (Reiter et al., [@B62], [@B64], [@B61]; Arnao and Hernandezruiz, [@B6]; Manchester et al., [@B48]). Specifically, melatonin has been reported to be effective in inhibiting the cell growth in some human pathogens by impairing their mitochondrial functions, inhibiting biofilm formation, and reducing intracellular substrates (Tekbas et al., [@B75]; Elmahallawy et al., [@B21]; Yang et al., [@B81]). For example, melatonin inhibits *Leishmania* via impairing the mitochondrial functions (Elmahallawy et al., [@B21]). Besides, melatonin mediated inhibition of the growth of a variety of cancer cells, such as hepatoma via the interference of fatty acid metabolism (Blask et al., [@B11],[@B12]; Sauer et al., [@B67]), colorectal cancer via the decrease of MT1 (melatonin receptor 1) (Farriol et al., [@B22]; Nemeth et al., [@B54]), pituitary tumor via the disturbance of nuclear receptor (Karasek et al., [@B38]). Importantly, a number of clinical trials have also confirmed that the use of melatonin is an effective measure to control a variety of disease, including the infectious diseases caused by pathogenic bacteria or virus, such as sepsis, Herpes (Sanchezbarcelo et al., [@B66]).

In plants, melatonin increases the resistance against pathogens via activating the expression of defense genes, elevating NO production, and thickening the cell wall (Yin et al., [@B82]; Lee et al., [@B42], [@B43]; Qian et al., [@B58]; Shi et al., [@B70], [@B71]; Zhao et al., [@B84]; Lee and Back, [@B41]; Wei et al., [@B78]). For example, various pathogenesis-related (PR) and defense genes that are activated by salicylic acid (SA) and ethylene (ET), have also been shown to be induced by melatonin in the Arabidopsis and tobacco (Lee et al., [@B42], [@B43]). Melatonin also induces NO production, which plays an important role in plant innate immunity response against bacterial pathogen attacks (Shi et al., [@B70]). It is also observed that melatonin is effective for thickening cell wall by inducing the accumulation of cellulose, galactose, xylose, and callose in plants to prevent pathogen infection (Qian et al., [@B58]; Zhao et al., [@B84]). Recently, studies on melatonin against plant pathogens indirectly by triggering the plant immunity have been explored. However, little is known about the direct interaction between melatonin and plant pathogens (Arnao and Hernandezruiz, [@B6]).

In this study, we investigated the direct effects of melatonin on *P. infestans*. The results and observations showed that the mycelial growth, cell ultrastructure, stress tolerance, and fungicide susceptibility of *P. infestans* could be significantly altered in the presence of melatonin. Because of the lack of the potato varieties resistant to late blight, the control of this notorious disease largely depends on the high dosage and frequency of fungicide application. Interestingly, the dosage of fungicide can be significantly reduced when it was combined with melatonin, which would be important for human health and the environment. Majority of the previous transcriptome studies focused on the host-*P. infestans* interaction (Gao et al., [@B25]; Ali et al., [@B3]; Frades et al., [@B23]; Ah-Fong et al., [@B1]), but our analysis of transcriptome were focused to reveal the underlying mechanism of melatonin against *P. infestans*. The key findings of this study will be useful to explore the melatonin-based alternate approaches for the late blight control in potato.

Materials and methods {#s2}
=====================

*P. infestans* strain, media, and culture conditions
----------------------------------------------------

T30-4 (A1 mating type) is the sequenced *P. infestans* isolate that is commonly used in laboratory research worldwide (Haas et al., [@B33]). It was provided by Dr. Suomeng Dong, Nanjing Agriculture University, China. The strain was cultured on Rye A agar at 18°C in the dark as described in previous report (Avrova et al., [@B7]).

Effects of melatonin on late blight of potato infected by *P. infestans* T30-4
------------------------------------------------------------------------------

*P. infestans* strain T30-4 was cultured on Rye A agar at 18°C in the dark for 14 days (Avrova et al., [@B7]). Then, the potato leaves and the tuber slices (2 cm × 3 cm × 3 mm in size) were sprayed with melatonin solution in varying concentrations (0, 1, 3, 6, 8, 10 mM) dissolved in DMSO, and the same volumes of DMSO as the control, and the water also as the control (CK) (excluding the influence on leaves and tubers by melatonin or DMSO). Then, the 7-mm-diameter T30-4 mycelial disks were put on the potato tuber slices and leaves (the melatonin team and DMSO team), then incubated at 18°C with a 12-h/12-h light/dark cycle for 5 days. The size of each lesion was measured then analyzed with the Student\'s *t*-test. Three biological repeats were performed for each experiment.

Measuring the effects of melatonin on mycelial growth of *P. infestans*
-----------------------------------------------------------------------

The 7-mm-diameter T30-4 mycelial disks were cultured on Rye A agar plates supplemented with varying concentrations of melatonin solution (0, 1, 1.5, 2, 3, and 5 mM), and the same volumes of DMSO as the control. The diameters of the colony were measured at the 9th day and 14th day. The inhibition rates were calculated using the diameter of control colony (D), drug-treated colony (M) as follows: \[(D -- M)/(D -- 0.7)\] × 100%. All experiments were repeated three times.

Measurements of the effects of melatonin on cell viability of *P. infestans*
----------------------------------------------------------------------------

MTT, 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide can be converted to formazan by the mitochondrial reductase of living cells. The 7-mm-diameter T30-4 mycelial disks were cultured on 96-well plates supplemented with DMSO (as control), melatonin (0, 3, 6, 10 mM), Infinito (0, 0.01, 0.05, 0.1 ml/L, ml/L stands for the volume of fungicide in 1 L water), and various combinations of melatonin + Infinito (3 + 0.01, 6 + 0.05, 10 mM + 0.1 ml/L), and incubated at 18°C for 24 h. After 24 h, 10 μL MTT solution was added and incubated at 18°C for 4 h. Then, the samples were measured in an automatic microplate reader working at a wavelength of 490 nm. The cell viability (%) = \[A (drug) -- A (mock)\]/\[A (control) -- A (mock)\].

Electron microscopy
-------------------

The T30-4 was cultured in liquid Rye A agar medium containing 6 mM melatonin and the same volumes of DMSO were set as the control, then incubated at 18°C in the dark for 9 days. Next, the mycelia were collected, fixed, observed for scanning electron microscope (SEM) and transmission electron microscope (TEM) as described in the literatures (Cao et al., [@B14]; Chen et al., [@B16]).

Stress tolerance assay
----------------------

1.  The 7-mm-diameter T30-4 mycelial disks were cultured on Rye A agar plates with different supplements: DMSO (as a control), melatonin (3 mM), NaCl (0.1 M)/H~2~O~2~ (0.1 mM), and a combination of melatonin + NaCl/H~2~O~2~. Then the disks were incubated at 18°C in the dark for 14 days.

2.  The 7-mm-diameter T30-4 mycelial disks were cultured on Rye A agar plates with different treatments: DMSO (as a control), melatonin (3 mM), UV (1,350 Mw/mm^2^) for 30 mins/37°C for 2 h/4°C for 24 h, and a combination of melatonin + UV/37°C/4°C. Then, the disks were incubated at 18°C in the dark for 14 days.

3.  After the 14 days, we measured the diameter of the colony and calculated the inhibition rates. All experiments were repeated three times.

Analysis of synergism/antagonism effect of the combination of melatonin and fungicide on *P. infestans*
-------------------------------------------------------------------------------------------------------

Infinito is a famous fungicide, manufactured by Bayer (Germany), mainly composed of Fluopicolide and Propamocab hydrochloride. The 7-mm-diameter T30-4 mycelial disks were cultured on Rye A agar plates supplemented with DMSO (as control), melatonin solution in DMSO (0, 1, 2, 3 mM), fungicide (0, 0.001, 0.005, 0.01 ml/L, ml/L stands for the volume of fungicide in 1 L water), and various combinations of melatonin + Infinito (1 + 0.001, 1 + 0.005, 1 + 0.01, 2 + 0.001, 2 + 0.005, 2 + 0.01, 3 + 0.001, 3 + 0.005, 3 mM + 0.01 ml/L), and incubated at 18°C for 14 days. Then, the diameters of the colony were measured and the inhibition rates were analyzed by using the Student\'s *t*-test. Each datum was from the average of three independent biological replicates. The interaction between melatonin and fungicide (Infinito) was quantitatively measured using Combination index (CI) value (Xiong et al., [@B79]). The levels of reagent interaction were defined following the previous report (Chou, [@B17]), synergism (CI \< 1), additive effect (CI = 1), or antagonism (CI \> 1). The percentage of growth value was calculated using the diameter of 14-day-old DMSO-treated control colony (D), and drug-treated colony (T) as follows: \[(T-0.7)/(D-0.7)\] × 100. IC50 (The half maximal inhibitory concentration) and CI values were calculated by using the CompuSyn software (Chou and Talalay, [@B18]). The affected value (Fa) indicated the growth inhibition of colony by drug was calculated using the program\'s instructions as follows: (100 -- % growth value)/100.

Pathogenicity test of *P. infestans* by using the combination of melatonin and fungicide
----------------------------------------------------------------------------------------

*P. infestans* strain T30-4 was cultured on Rye A agar at 18°C in the dark for 14 days (Avrova et al., [@B7]). Then, potato leaves and tuber slices (2 cm × 3 cm × 3 mm in size) were sprayed with DMSO (as control), melatonin solution (3, 6, 8 mM), Infinito (0.0025, 0.025, 0.25 ml/L), and melatonin + Infinito (3 + 0.0025, 3 + 0.025, 3 + 0.25, 6 + 0.0025, 6 + 0.025, 6 + 0.25, 8 + 0.0025, 8 + 0.025, 8 mM + 0.25 ml/L). The 7-mm-diameter T30-4 mycelial disks were put on the potato tuber slices and leaves, and incubated at 18°C with a 12-h/12-h light/dark cycle for 5 days. Then, the size of each lesion was measured and analyzed with the Student\'s *t*-test. Three biological repeats were performed for each experiment.

Transcriptome assay and the dataset analysis
--------------------------------------------

The T30-4 was chosen for the RNA-Seq (Haas et al., [@B33]). The T30-4 was cultured for 14 days in liquid Rye A agar medium at 18°C in the dark. Then the mycelia were transplanted to liquid Rye A agar medium containing with 3 mM melatonin (IC50: half maximal inhibitory concentration) and the same volumes of DMSO as the control, where mycelia were cultured at 18°C in the dark for 24 h. The mycelia were collected and frozen in liquid nitrogen for transcriptome studies. The total RNA was extracted from the samples using the RNAprep Pure Plant Kit (TianGen Biotech, Beijing, China). Three biological replicates were employed in the transcriptome experiments. The sequencing libraries were generated using the NEBNext® Ultra™ RNA Library Prep Kit for Illumina® (NEB, USA) following the manufacturer\'s recommendations. These libraries were sequenced on an Illumina Hiseq platform and 125 bp/150 bp paired-end reads were generated. Reference genome and gene model annotation files were downloaded from the genome website directly. Paired-end clean reads were aligned to the reference genome using TopHat v2.0.12. HTSeq v0.6.1 was used to count the numbers of reads mapped to each gene. Then, FPKM of each gene was calculated based on the length of the gene and read counts mapped to this gene. Differential expression analysis was performed using the DESeq R package (1.18.0). Genes with an adjusted *p* \< 0.05 found by DESeq were regarded as the differentially expressed ones. Gene Ontology (GO) enrichment analysis of differentially expressed genes was implemented by the GO seq R package. GO terms with corrected *p* \< 0.05 were considered as significant ones. The KOBAS software was used to test the statistical enrichment of differential expression genes in KEGG pathway. The transcriptome datasets were submitted to NCBI and the accession number---[PRJNA415528](PRJNA415528).

Real-time quantitative RT-PCR (qRT-PCR) assay
---------------------------------------------

The mycelia were cultured and collected as described in RNA-seq. The total RNA was extracted from the mycelia by using the RNAprep Pure Plant Kit (TianGen Biotech, Beijing, China). The total RNA (1 μg) was used for reverse transcription reaction by using the PrimeScript RT Kit (TAKARA Biotech). After that, the TransStart TopGreen qPCR Super Mix (TransGen Biotech) was used for the qRT-PCR assays by a Bio-Rad CFX96 System. Primer sequences for qRT-PCR were listed in Table [S1](#SM5){ref-type="supplementary-material"}. Each datum was averaged from three independent biological replicates.

Results and discussion {#s3}
======================

Potato late blight can be significantly attenuated by melatonin *in vivo*
-------------------------------------------------------------------------

It has been proven that melatonin displays multiple effects on the cell growth and development of plants, animals and humans (Pandi-Perumal et al., [@B56]; Reiter et al., [@B63]), but the impact of melatonin on *P. infestans* has not been explored. For this aim, the T30-4 strain, was inoculated on the potato leaves and tuber slices which were pretreated with DMSO (mock) and various concentrations of melatonin solution. The *in vivo* assay showed that the lesion sizes of leaves and tuber slices infected by *P. infestans* were gradually reduced by increasing melatonin concentrations, and no toxic effects to leaves or tuber even at the highest concentration of melatonin were observed (Figures [1A--D](#F1){ref-type="fig"}). The occurrence of potato late blight can be prevented on leaves and tuber slices when the concentration of melatonin reached 10 mM (Figures [1A--D](#F1){ref-type="fig"}). Thus, these *in vivo* observations showed that the potato late blight can be significantly attenuated by using melatonin.

![Melatonin suppress potato late blight in a dose dependent manner. **(A,B)** Disease symptoms of potato late blight on leaves **(A)** and fresh tuber slices **(B)** were captured after inoculation of T30-4 strain for 5 days. The leaves and slices were pretreated with water (CK, without inoculation with *P. infestans*), DMSO, and different concentrations of melatonin. **(C,D)** The dose-effect curves of melatonin against *P. infestans* on potato leaves **(C)** and tuber slices **(D)**. (^\*^*P* \< 0.05, ^\*\*^*P* \< 0.01, ^\*\*\*^*P* \< 0.001). Each data point was average of three independent biological replicates.](fpls-08-01993-g0001){#F1}

Suppressing the mycelial growth of *P. infestans* by melatonin *in vitro*
-------------------------------------------------------------------------

The previous studies have shown that melatonin can act as an important signal to induce innate immunity in plants (Yin et al., [@B82]; Lee et al., [@B42], [@B43]; Qian et al., [@B58]; Shi et al., [@B70], [@B71]; Zhao et al., [@B84]; Lee and Back, [@B41]; Wei et al., [@B78]). To exclude the effects of plant immunity induced by melatonin on the occurrence of potato late blight, we next investigated whether melatonin can directly suppress the cell growth of *P. infestans*. Toward this objective, the strain T30-4 was cultured on the medium supplemented with different concentrations of melatonin. When higher concentrations of melatonin were used, slower growth of mycelia was observed (Figures [2A,B](#F2){ref-type="fig"}). The IC50 of melatonin appeared at 3 mM for T30-4 (Figures [2A,B](#F2){ref-type="fig"}). The mycelial growth was completely inhibited at a melatonin concentration of 5 mM (Figures [2A,B](#F2){ref-type="fig"}). Furthermore, after being incubated for 24 h with different concentrations of melatonin, the mycelial cell viability was tested by the MTT reduction assay. This assay showed that the cell viability was decreased with increases in melatonin concentration (Figure [2C](#F2){ref-type="fig"}). These *in vitro* observations suggested that melatonin could directly suppress the cell growth of *P. infestans* to attenuate the potato late blight, which was consistent with the previous studies that exogenous melatonin directly resists the human pathogens *in vitro*, including *Leishmania infantum, Candida parapsilosis, Staphylococcus aureus* (Tekbas et al., [@B75]; Elmahallawy et al., [@B21]; Yang et al., [@B81]).

![Melatonin can suppress the growth of *P. infestans in vitro*. **(A)** Mycelial phenotypes of *P. infestans* grown on the medium supplemented with melatonin for 9 days (upper panel) and 14 days (below panel). The strain T30-4 was cultured for on Rye A agar amended with 3 or 5 mM melatonin. **(B)** Dose-dependent effect of melatonin on the mycelial inhibition rate of T30-4 at 9 and 14 days. The strain T30-4 was treated with DMSO (control) and melatonin at 1, 1.5, 2, 3, and 5 mM, respectively (^\*^*P* \< 0.05, ^\*\*^*P* \< 0.01, ^\*\*\*^*P* \< 0.001). Each data point was averaged of three independent biological replicates. **(C)** MTT reduction assay showed that cell viability of *P. infestans* T30-4 under melatonin treatment for 24 h. The strain T30-4 was treated with DMSO (control) and melatonin at 3, 6, 10 mM (^\*^*P* \< 0.05, ^\*\*^*P* \< 0.01, ^\*\*\*^*P* \< 0.001).](fpls-08-01993-g0002){#F2}

Influencing the ultrastructure of *P. infestans* by melatonin
-------------------------------------------------------------

To understand the growth inhibition phenotypes of *P. infestans* caused by melatonin treatment, the cell ultrastructure of the melatonin-treated *P. infestans* was investigated using scanning electron microscopy (SEM) and transmission electron microscopy (TEM). As shown in Figures [3A,B](#F3){ref-type="fig"}, the disorganized hyphal growth pattern, and aberrant and distorted hyphae were observed in melatonin-treated *P. infestans* in comparison with the untreated controls; this could result in the inhibition of hyphal growth of *P. infestans*. In melatonin-treated *P. infestans*, the branched hyphae and blunt hyphal tip (Figures [3B,D](#F3){ref-type="fig"}), possibly was a result of suppressing the apical dominance of the hyphal tip that could lead to the inhibition of hyphal elongation (Semighini and Harris, [@B69]; Zhao et al., [@B83]). Furthermore, the TEM analysis showed that more vacancies and fewer lipid droplets appeared in the cells of *P. infestans* with melatonin treatment compared to the control (Figures [3E,F](#F3){ref-type="fig"}), indicating that the melatonin treatment resulted in the decrease of lipid droplets in *P. infestans*. It is well-known that lipid droplets play an important role in various biological processes, such as facilitation of cell growth, propagation as well as infection of fungus, viral and bacterium (Bago et al., [@B8]; Stehr et al., [@B73]; Radulovic et al., [@B60]; Kobae et al., [@B39]; Bi et al., [@B10]). Thus, the reduction of lipid droplets could result in the inhibition of growth of *P. infestans*.

![SEM and TEM analysis of melatonin treated *P. infestans*. Ultrastructure of **(A)** hyphal surface untreated by melatonin documented by SEM, **(B)** hyphal surface treated by melatonin documented by SEM, **(C)** hyphal tip untreated by melatonin documented by SEM, **(D)** hyphal tip treated by melatonin documented by SEM, **(E)** hypha untreated by melatonin documented by TEM. LP, lipid droplet, **(F)** hypha treated by melatonin documented by TEM. VA, vacancy.](fpls-08-01993-g0003){#F3}

Enhanced susceptibility of *P. infestans* to various environmental stresses in the presence of melatonin
--------------------------------------------------------------------------------------------------------

The tolerance of *P. infestans* to environmental stresses derived from salt, heat, cold and Ultra Violate (UV) radiation can promote the successful occurrence and epidemics of potato late blight (Ortizurquiza and Keyhani, [@B55]). We therefore explored the tolerance of *P. infestans* to these stresses and the combination of these stresses with melatonin. The mycelial growth of *P. infestans* was inhibited when using salt, UV, heat, H~2~O~2~ and cold, respectively (Figures [4A--C,E,G,I,K,M](#F4){ref-type="fig"}), indicating that *P. infestans* was sensitive to these types of environmental stresses. Interestingly, the mycelial growth of *P. infestans* was more severely inhibited by the pairwise combination of melatonin and these stresses (UV/salt/heat) than that of melatonin or any of these stresses alone (Figures [4A--F,I,J,M](#F4){ref-type="fig"}). These results indicated that melatonin reduced the stress tolerance of *P. infestans* under challenging environmental conditions.

![Growth pattern of *P. infestans* in response to the treatment of DMSO, melatonin, stress, and melatonin + stress. Colony morphology of *P. infestans* grown on Rye A agar medium treated by **(A--L)** DMSO, 3 mM melatonin, UV, 3 mM melatonin + UV, 0.1 M NaCl, 3 mM melatonin + 0.1 M NaCl, 0.1 mM H~2~O~2~, 3 mM melatonin + 0.1 mM H~2~O~2~, 37°C, 3 mM melatonin + 37°C, 4°C, 3 mM melatonin + 4°C. **(M)** Colony diameter of *P. infestans* grown on Rye A agar medium treated by DMSO, 3 mM melatonin, UV/NaCl/H~2~O~2~/37°C/4°C, 3 mM melatonin + UV/NaCl/H~2~O~2~/37°C/4°C. Capitalized letters indicate significant difference, *p* \< 0.01.](fpls-08-01993-g0004){#F4}

Melatonin and chemical fungicide synergistically inhibit the growth of *P. infestans in vitro*
----------------------------------------------------------------------------------------------

Currently, the control of potato late blight mainly depends on high dosage and frequency of fungicide applications. These practices result in many health and environmental issues. Reduced fungicide doses are important for a sustainable environment. It has been reported that melatonin could be used as a synergist to reduce the use of some drugs and enhance the drug effect, for example, vincristine, atorvastatin, vitamin C and E (Lissoni et al., [@B44]; Gitto et al., [@B27]; Casadozapico et al., [@B15]; Dayoub et al., [@B19]). We therefore examined whether the synergistic effects exist in combined application of melatonin and fungicide against *P. infestans*. Infinito is one of the most effective, expensive and extensively used chemical fungicides for potato late blight control. The results showed that the inhibitory effects of T30-4 treated with Infinito + melatonin was more significantly enhanced than that of Infinito or melatonin alone (Figures [5A,B](#F5){ref-type="fig"}); this suggested that melatonin can promote *P. infestans* to become more susceptible to Infinito. The IC50s of melatonin, Infinito, and melatonin + Infinito were also examined, and the values were 3 mM, 0.005 ml/L, 2 mM + 0.0005 ml/L, respectively. A significant reduction of Infinito dose (10-fold reduction) was generated by co-applying melatonin (Figure [5A](#F5){ref-type="fig"}), which indicated that the chemical fungicide dose was decreased when combined with melatonin for potato late blight control. Moreover, CI \< 1 was observed, confirming that the synergistic effects exist in the melatonin + Infinito (Figure [5C](#F5){ref-type="fig"}). The MTT reduction assay also confirmed that the cell viability of T30-4 treated with Infinito + melatonin was more significantly decreased than that of Infinito or melatonin alone (Figure [5D](#F5){ref-type="fig"}). Thus, these observations provide new insights into the synergistic anti-fungal effects of Infinito with melatonin on *P. infestans*, and expand the understanding of the synergistic effect of melatonin (Lissoni et al., [@B44]; Casadozapico et al., [@B15]; Dayoub et al., [@B19]).

![Synergistic growth inhibition of *P. infestans* induced by co-application of the melatonin and Infinito. **(A)** Colony morphology on Rye A agar medium that contains DMSO, 3 mM melatonin (IC50), 0.005 ml/L Infinito (IC50), 2 mM melatonin + 0.0005 ml/L Infinito (IC50), 3 mM melatonin + 0.005 ml/L Infinito. **(B)** Mycelial inhibition rate of *P. infestans* T30-4 under DMSO, melatonin, Infinito, and melatonin + Infinito treatment for 14 days. Each data point was averaged from three independent biological replicates. Capitalized letters indicate significant difference, *p* \< 0.01. **(C)** Fa-CI curve showed synergism (CI \< 1) generated by melatonin + Infinito treatment. **(D)** MTT reduction assay showed that cell viability of *P. infestans* T30-4 under DMSO, melatonin, Infinito, and melatonin + Infinito treatment for 24 h. Lower case letters indicate significant difference, *p* \< 0.05.](fpls-08-01993-g0005){#F5}

Melatonin reduced the fungicide dose for potato late blight control *in vivo*
-----------------------------------------------------------------------------

Next, the *in vivo* assay of synergistic inhibition was conducted. When treated with melatonin + Infinito, the lesion sizes infected by *P. infestans* on the potato leaves and tuber slices were much smaller than that of melatonin or Infinito alone (Figures [6A--D](#F6){ref-type="fig"}, and Figures [S1A,B](#SM1){ref-type="supplementary-material"}). The 6 mM melatonin + 0.025 ml/L Infinito was the optimal concentration among these combinations (the lowest concentration of Infinito for reaching the same small lesion size, while the concentration of melatonin was modest) (Figures [S1A,B](#SM1){ref-type="supplementary-material"}). A significant reduction of Infinito dose (10-fold reduction) was achieved by the combination with melatonin *in vivo* (Figures [6E,F](#F6){ref-type="fig"}). This result revealed an eco-friendly potential for the reduced use of fungicides by co-application of melatonin in potato late blight control.

![Disease symptoms of potato late blight on leaves and tubers slices infected by *P. infestans* for 5 days in the presence of melatonin and Infinito. **(A)** Disease symptoms of potato leaves with the treatment of DMSO, 6 mM melatonin, 0.025 ml/L Infinito, 6 mM melatonin + 0.025 ml/L Infinito, respectively, after 5 days. **(B)** Disease symptoms of potato tuber slices with the treatment of DMSO, 6 mM melatonin, 0.025 ml/L Infinito, 6 mM melatonin + 0.025 ml/L Infinito, respectively, after 5 days. **(C)** Lesion size of leaves with the treatment of 6 mM melatonin, 0.025 ml/L Infinito, 6 mM melatonin + 0.025 ml/L Infinito, respectively, after 5 days. **(D)** Lesion size of tuber slices with the treatment of 6 mM melatonin, 0.025 ml/L Infinito, 6 mM melatonin + 0.025 ml/L Infinito, respectively, after 5 days. **(E)** The lesion size of leaves infected by *P. infestans* treated with 6 mM melatonin, 0.025 ml/L Infinito, 3 mM melatonin + 0.0025 ml/L Infinito, respectively, after 5 days. **(F)** The lesion size of tuber slices under the treatment of 6 mM melatonin, 0.025 ml/L Infinito, 3 mM melatonin + 0.0025 ml/L Infinito, respectively, after 5 days. Each data point was averaged of three independent biological replicates. Capitalized letters indicate significant difference, *p* \< 0.01](fpls-08-01993-g0006){#F6}

Analysis of melatonin effects on *P. infestans* by the transcriptome
--------------------------------------------------------------------

To further investigate the underlying molecular mechanism about the roles of melatonin in the growth and development of *P. infestans*, we performed transcriptome analysis to assess the global transcriptional profile revealing differentially expressed genes (DEGs) induced by melatonin. The T30-4 strain was treated with DMSO (mock) and 3 mM melatonin for 24 h and the samples were collected for transcriptome assay. After trimming for quality and adapter sequences, 45.79 and 47.89 million transcriptome reads were obtained with the treatments of 3 mM melatonin and DMSO as the control, respectively (Figure [7A](#F7){ref-type="fig"}), of which 85.73, 5.88, and 79.85% reads could be mapped to the annotated genome, multiple genes, and unique genes of *P. infestans*, respectively (Figure [7B](#F7){ref-type="fig"}). 1,279 DEGs out of 10,844 detected genes were identified in the melatonin- treated samples in contrast to DMSO-treated one (Table [S2](#SM6){ref-type="supplementary-material"}). Among these DEGs, 809 were significantly up-regulated and 470 significantly down-regulated (Figure [7C](#F7){ref-type="fig"}). The heat-map also showed that melatonin treatment was tend to increase the gene expression level (FPKM) of the DEGs (Figure [7D](#F7){ref-type="fig"} and Figure [S2](#SM2){ref-type="supplementary-material"}, Table [S3](#SM7){ref-type="supplementary-material"}).

![Summary of the basic information for the transcriptome data. **(A)** High-quality clean reads from high-throughput sequencing. **(B)** Proportions of high-quality clean reads of unmapped to genes, mapped to unique genes and multiple genes. **(C)** The number of differentially expressed genes (DEGs). **(D)** The heat-map of DEGs induced by melatonin.](fpls-08-01993-g0007){#F7}

To investigate the detailed functions of melatonin\'s effects on *P. infestans*, the GO terms and KEGG pathways were analyzed. In the transcriptome, among the top 30 GO terms and KEGG pathways (sorted by their *p*-values in the descending order; Tables [S4A,B](#SM8){ref-type="supplementary-material"}, [S5A,B](#SM9){ref-type="supplementary-material"}), there were 19 GO terms and 26 KEGG pathways associated with the metabolism of carbohydrates, lipids, nucleic acid, amino acid, cofactors and vitamins (Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}). Notably, among 19 GO terms and 26 KEGG pathways, the down-regulated genes were predominated in 14 GO terms and 14 KEGG pathways (Table [3](#T3){ref-type="table"}), suggesting that the various metabolic processes in *P. infestans* are dramatically suppressed after melatonin treatment.

###### 

Nineteen GO terms related to metabolism in top30 GO terms in transcriptome.

  **Description**                                       **Classification**                       **Number of genes up regulated**   **Number of genes down regulated**
  ----------------------------------------------------- ---------------------------------------- ---------------------------------- ------------------------------------
  Organic acid metabolic process                        Organic acid metabolic process           27                                 30
  Oxoacid metabolic process                             Organic acid metabolic process           27                                 30
  Carboxylic acid metabolic process                     Organic acid metabolic process           27                                 29
  Pyruvate metabolic process                            Organic acid metabolic process           0                                  12
  Branched-chain amino acid biosynthetic process        Cellular amino acid metabolic process    0                                  8
  Cellular amino acid biosynthetic process              Cellular amino acid metabolic process    17                                 8
  Branched-chain amino acid metabolic process           Cellular amino acid metabolic process    0                                  8
  ATP generation from ADP                               Nucleotide metabolic process             0                                  11
  ADP metabolic process                                 Nucleotide metabolic process             0                                  11
  Purine ribonucleoside diphosphate metabolic process   Nucleoside phosphate metabolic process   0                                  11
  Ribonucleoside diphosphate metabolic process          Nucleoside phosphate metabolic process   0                                  11
  Purine nucleoside diphosphate metabolic process       Nucleoside phosphate metabolic process   0                                  11
  rRNA processing                                       Nucleic acid metabolic process           14                                 0
  rRNA metabolic process                                Nucleic acid metabolic process           14                                 0
  ncRNA processing                                      Nucleic acid metabolic process           22                                 0
  RNA processing                                        Nucleic acid metabolic process           32                                 0
  Oxidation-reduction process                           Single-organism metabolic process        44                                 45
  Single-organism carbohydrate catabolic process        Carbohydrate catabolic process           1                                  11
  Glycolytic process                                    Carbohydrate catabolic process           0                                  11

*The classification based on quick GO, website: <http://www.ebi.ac.uk/QuickGO/>*.

###### 

Twenty-six KEGG pathways related to metabolism in top30 KEGG pathways in transcriptome.

  **Description**                               **Classification**                                 **Number of genes up regulated**   **Number of genes down regulated**
  --------------------------------------------- -------------------------------------------------- ---------------------------------- ------------------------------------
  Glycolysis/Gluconeogenesis                    Metabolism; Carbohydrate metabolism                4                                  16
  Pyruvate metabolism                           Metabolism; Carbohydrate metabolism                4                                  6
  Galactose metabolism                          Metabolism; Carbohydrate metabolism                0                                  4
  Fructose and mannose metabolism               Metabolism; Carbohydrate metabolism                0                                  3
  Pentose and glucuronate interconversions      Metabolism; Carbohydrate metabolism                5                                  1
  Ascorbate and aldarate metabolism             Metabolism; Carbohydrate metabolism                3                                  0
  Glycerolipid metabolism                       Metabolism; Lipid metabolism                       4                                  6
  Alanine, aspartate and glutamate metabolism   Metabolism; Amino acid metabolism                  6                                  1
  Cysteine and methionine metabolism            Metabolism; Amino acid metabolism                  4                                  0
  Valine, leucine and isoleucine degradation    Metabolism; Amino acid metabolism                  6                                  0
  Valine, leucine and isoleucine biosynthesis   Metabolism; Amino acid metabolism                  0                                  4
  Arginine and proline metabolism               Metabolism; Amino acid metabolism                  9                                  1
  Glutathione metabolism                        Metabolism; Metabolism of other amino acids        3                                  4
  Cyanoamino acid metabolism                    Metabolism; Metabolism of other amino acids        3                                  3
  Beta-Alanine metabolism                       Metabolism; Metabolism of other amino acids        3                                  0
  Taurine and hypotaurine metabolism            Metabolism; Metabolism of other amino acids        1                                  1
  Pyrimidine metabolism                         Metabolism; Nucleotide metabolism                  19                                 2
  Purine metabolism                             Metabolism; Nucleotide metabolism                  19                                 5
  Biosynthesis of amino acids                   Metabolism; Overview                               9                                  16
  Carbon metabolism                             Metabolism; Overview                               4                                  20
  Degradation of aromatic compounds             Metabolism; Overview                               1                                  2
  2-Oxocarboxylic acid metabolism               Metabolism; Overview                               2                                  5
  Pantothenate and CoA biosynthesis             Metabolism; Metabolism of cofactors and vitamins   0                                  5
  Porphyrin and chlorophyll metabolism          Metabolism; Metabolism of cofactors and vitamins   2                                  3
  Folate biosynthesis                           Metabolism; Metabolism of cofactors and vitamins   3                                  0
  Nitrogen metabolism                           Metabolism; Energy metabolism                      2                                  3

*The classification based on the KEGG pathway database, <http://www.genome.jp/kegg/>*.

###### 

The prominent down-regulated genes in 14 GO terms and 14 KEGG pathways related to metabolism in transcriptome.

                                                        **Classification**                                 **Number of genes up regulated**   **Number of genes down regulated**
  ----------------------------------------------------- -------------------------------------------------- ---------------------------------- ------------------------------------
  **GO TERM**                                                                                                                                 
  Organic acid metabolic process                        Organic acid metabolic process                     27                                 30
  Oxoacid metabolic process                             Organic acid metabolic process                     27                                 30
  Carboxylic acid metabolic process                     Organic acid metabolic process                     27                                 29
  Pyruvate metabolic process                            Organic acid metabolic process                     0                                  12
  Branched-chain amino acid biosynthetic process        Cellular amino acid metabolic process              0                                  8
  Branched-chain amino acid metabolic process           Cellular amino acid metabolic process              0                                  8
  ATP generation from ADP                               Nucleotide metabolism                              0                                  11
  ADP metabolic process                                 Nucleotide metabolism                              0                                  11
  Purine ribonucleoside diphosphate metabolic process   Nucleotide metabolism                              0                                  11
  Ribonucleoside diphosphate metabolic process          Nucleotide metabolism                              0                                  11
  Purine nucleoside diphosphate metabolic process       Nucleotide metabolism                              0                                  11
  Oxidation-reduction process                           Single-organism metabolic process                  44                                 45
  Single-organism carbohydrate catabolic process        Carbohydrate catabolic process                     1                                  11
  Glycolytic process                                    Carbohydrate catabolic process                     0                                  11
  **KEGG PATHWAY**                                                                                                                            
  Glycolysis/Gluconeogenesis                            Metabolism; Carbohydrate metabolism                4                                  16
  Pyruvate metabolism                                   Metabolism; Carbohydrate metabolism                4                                  6
  Galactose metabolism                                  Metabolism; Carbohydrate metabolism                0                                  4
  Fructose and mannose metabolism                       Metabolism; Carbohydrate metabolism                0                                  3
  Glycerolipid metabolism                               Metabolism; Lipid metabolism                       4                                  6
  Valine, leucine and isoleucine biosynthesis           Metabolism; Amino acid metabolism                  0                                  4
  Glutathione metabolism                                Metabolism; Metabolism of other amino acids        3                                  4
  Biosynthesis of amino acids                           Metabolism; Overview                               9                                  16
  Carbon metabolism                                     Metabolism; Overview                               4                                  20
  Degradation of aromatic compounds                     Metabolism; Overview                               1                                  2
  2-Oxocarboxylic acid metabolism                       Metabolism; Overview                               2                                  5
  Pantothenate and CoA biosynthesis                     Metabolism; Metabolism of cofactors and vitamins   0                                  5
  Porphyrin and chlorophyll metabolism                  Metabolism; Metabolism of cofactors and vitamins   2                                  3
  Nitrogen metabolism                                   Metabolism; Energy metabolism                      2                                  3

Differentially expressed genes related to amino acid metabolism of *P. infestans* were significantly affected by melatonin
--------------------------------------------------------------------------------------------------------------------------

Among these altered metabolic processes in transcriptome (top 30 GO terms and KEGG pathways), the number of GO terms and KEGG pathways related to amino acid metabolism was the largest (three GO terms and ten KEGG pathways) (Table [4](#T4){ref-type="table"}, Table [S6A](#SM10){ref-type="supplementary-material"}). This result indicated that the amino acid metabolism was the most significantly targeted metabolic process by melatonin. Among these GO terms and KEGG pathways associated with amino acid metabolism (Tables [S6A,B](#SM10){ref-type="supplementary-material"}), the biosynthesis of amino acids was the overview pathway in which the down-regulated genes were predominant (Table [3](#T3){ref-type="table"}). Particularly, the genes encoding rate-limiting enzymes: pyruvate kinase, fructose-bisphosphate aldolase, isocitrate dehydrogenase \[NADP\] were down-regulated as well (Table [5](#T5){ref-type="table"}, Tables [S6A,B](#SM10){ref-type="supplementary-material"}). The genetic mutation of these rate-limiting enzymes can reduce amino acid metabolism levels (Heneka et al., [@B35]; Malay et al., [@B47]; Gupta and Bamezai, [@B32]; Grace et al., [@B28]; Lv et al., [@B46]), indicating that the amino acid metabolism was suppressed after melatonin treatment. Collectively, the results and observations from the transcriptome suggest that amino acid metabolism of *P. infestans* is likely the main target of melatonin.

###### 

The GO term or KEGG pathway related to metabolism of amino acid, carbohydrate, nucleic acid, lipid.

  -------------------------------------------- ------------------ -----------------------------------------------------
  **Amino acid metabolic process**             **GO Term**        
                                               **Amount**         **Description**
                                               3                  Branched-chain amino acid biosynthetic process
                                                                  Cellular amino acid biosynthetic process
                                                                  Branched-chain amino acid metabolic process
                                               **KEGG pathway**   
                                               **Amount**         **Description**
                                               10                 Alanine, aspartate and glutamate metabolism
                                                                  Cysteine and methionine metabolism
                                                                  Valine, leucine and isoleucine degradation
                                                                  Valine, leucine and isoleucine biosynthesis
                                                                  Arginine and proline metabolism
                                                                  Glutathione metabolism
                                                                  Cyanoamino acid metabolism
                                                                  Beta-Alanine metabolism
                                                                  Taurine and hypotaurine metabolism
                                                                  Biosynthesis of amino acids
  **Nucleic acid metabolic process**           **GO Term**        
                                               **Amount**         **Description**
                                               4                  rRNA processing
                                                                  rRNA metabolic process
                                                                  ncRNA processing
                                                                  RNA processing
  **Nucleotide metabolic process**             **GO Term**        
                                               **Amount**         **Description**
                                               2                  ATP generation from ADP
                                                                  ADP metabolic process
                                               **KEGG pathway**   
                                               **Amount**         **Description**
                                               2                  Pyrimidine metabolism
                                                                  Purine metabolism
  **Nucleoside phosphate metabolic process**   **GO Term**        
                                               **Amount**         **Description**
                                               3                  Ribonucleoside diphosphate metabolic process
                                                                  Purine nucleoside diphosphate metabolic
                                                                  Purine ribonucleoside diphosphate metabolic process
  **Organic acid metabolic process**           **GO Term**        
                                               **Amount**         **Description**
                                               4                  Organic acid metabolic process
                                                                  Oxoacid metabolic process
                                                                  Carboxylic acid metabolic process
                                                                  Pyruvate metabolic process
  **Carbohydrate metabolic process**           **GO Term**        
                                               **Amount**         **Description**
                                               2                  Glycolytic process
                                                                  Single-organism carbohydrate catabolic process
                                               **KEGG pathway**   
                                               **Amount**         **Description**
                                               6                  Glycolysis/Gluconeogenesis
                                                                  Pyruvate metabolism
                                                                  Galactose metabolism
                                                                  Fructose and mannose metabolism
                                                                  Pentose and glucuronate interconversions
                                                                  Ascorbate and aldarate metabolism
  **Lipid metabolism**                         **KEGG pathway**   
                                               **Amount**         **Description**
                                               1                  Glycerolipid metabolism
  **Cofactors and vitamins metabolism**        **KEGG pathway**   
                                               **Amount**         **Description**
                                               3                  Pantothenate and CoA biosynthesis
                                                                  Porphyrin and chlorophyll metabolism
                                                                  Folate biosynthesis
  -------------------------------------------- ------------------ -----------------------------------------------------

###### 

The DEG related to biosynthesis of amino acid.

  **Gene ID**                       **log2FC**   **Padj**   **Interpro description**
  --------------------------------- ------------ ---------- ------------------------------------------------------------------------------
  **BIOSYNTHESIS OF AMINO ACIDS**                           
  [PITG_13402](PITG_13402)          0.80214      2.88E-06   Cystathionine beta-lyase
  [Novel01245](Novel01245)          −0.76229     0.015307   
  [PITG_01940](PITG_01940)          −1.0332      1.46E-06   Triosephosphate isomerase/glyceraldehyde-3-phosphate dehydrogenase, putative
  [PITG_17516](PITG_17516)          0.70944      0.000041   S-adenosylmethionine synthase
  [PITG_14696](PITG_14696)          0.4306       0.036763   Serine hydroxymethyltransferase
  [PITG_20970](PITG_20970)          −0.52586     0.023256   Triosephosphate isomerase/glyceraldehyde-3-phosphate dehydrogenase, putative
  [PITG_03598](PITG_03598)          −0.96851     5.02E-09   6-phosphofructokinase, putative
  [PITG_03599](PITG_03599)          0.61407      0.000949   Alanine aminotransferase 2
  [PITG_13116](PITG_13116)          −1.3446      2.08E-17   Triosephosphate isomerase
  [PITG_02049](PITG_02049)          0.56454      0.003107   Citrate synthase
  [PITG_12161](PITG_12161)          0.51372      0.011304   Delta-1-pyrroline-5-carboxylate synthetase
  [PITG_23158](PITG_23158)          −0.4919      0.018664   Isocitrate dehydrogenase \[NADP\]
  [PITG_01938](PITG_01938)          −1.0026      0.002778   Glyceraldehyde-3-phosphate dehydrogenase
  [PITG_01939](PITG_01939)          −0.93518     0.023748   Glyceraldehyde-3-phosphate dehydrogenase, putative
  [PITG_07400](PITG_07400)          −0.92768     2.63E-08   Phosphoglycerate mutase
  [PITG_21697](PITG_21697)          −0.95046     1.09E-07   conserved hypothetical protein
  [PITG_22685](PITG_22685)          −1.1672      2.27E-12   Dihydroxy-acid dehydratase, putative
  [PITG_02925](PITG_02925)          −1.4579      1.13E-20   Ketol-acid reductoisomerase
  [PITG_02786](PITG_02786)          −0.90929     6.57E-07   Fructose-bisphosphate aldolase
  [PITG_02740](PITG_02740)          −0.5491      0.004195   Acetolactate synthase
  [PITG_09393](PITG_09393)          −0.55962     0.002885   Pyruvate kinase
  [PITG_20759](PITG_20759)          −0.50352     0.019167   Dihydroxy-acid dehydratase
  [PITG_00221](PITG_00221)          0.53793      0.010979   Tryptophan synthase, putative
  [PITG_02210](PITG_02210)          1.2957       6.82E-14   Phenylalanine-4-hydroxylase, henna-like protein
  [PITG_05374](PITG_05374)          0.62953      0.000536   Argininosuccinate synthase

Carbohydrate metabolism and lipid metabolism were also altered in transcriptome (Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, [4](#T4){ref-type="table"} and Tables [S6C,D](#SM10){ref-type="supplementary-material"}). For example, the down-regulation of the rate-limiting enzyme 6-phosphofructokinase (PFK) in the transcriptome (Table [S6C](#SM10){ref-type="supplementary-material"}) would reduce the carbohydrate metabolism levels of *P. infestans* by melatonin (Raben et al., [@B59]; Wegener and Krause, [@B77]). The down-regulation of another rate-limiting enzyme fatty acid synthase (FASN) in transcriptome (Table [S6D](#SM10){ref-type="supplementary-material"}) documented that the suppression of lipid metabolism of *P. infestans* by melatonin (Smith et al., [@B72]), which is possibly the reason for the decrease in lipid droplets observed in TEM analysis of melatonin-treated samples.

In summary, the transcriptome analysis showed that multiple metabolic processes were affected by melatonin in *P. infestans*, especially amino acid metabolism. The perturbation of amino acid metabolism leads to cell death (Mizushima, [@B52]; Green et al., [@B29]), indicating that the disruption of amino acid metabolism homeostasis by melatonin may significantly contribute to the inhibition of growth in *P. infestans*. The previous study also showed that amino acid metabolism of *P. infestans* may be an important metabolic target for fungicides (Grenvillebriggs et al., [@B30]). Additionally, the amino acid metabolism has been a target to control the plant pathgens by some fungicides, such as pyrimethanil (Milling and Richardson, [@B50]). Thus, the results from this study imply that the target of amino acid metabolism in *P. infestans* by melatonin could be a novel alternative for the biocontrol of potato late blight.

Differentially expressed genes related to stress tolerance of *P. infestans* were affected by melatonin
-------------------------------------------------------------------------------------------------------

Though metabolic processes in *P. infestans* were significantly suppressed after melatonin treatment, the expression of some DEGs related to stress tolerance was also affected by melatonin. The transcriptome data showed that 15 DEGs were related to stress tolerance (Table [6](#T6){ref-type="table"}). Among them, 9 DEGs were down-regulated and 6 DEGs were up-regulated. Especially, two DEGs encoding the heat shock 70 kDa protein (HSP70) were significantly down-regulated. The HSP70 is one of the most prominent stress proteins and can be induced by a variety of stresses, such as UV radiation, heat shock, hypertonicity and low temperature (Tavaria et al., [@B74]; Alfieri et al., [@B2]; Fulgentini et al., [@B24]). This result showed that the deregulation of genes associated with the stress tolerance and especially the down-regulation of the genes encoding the HSP70, probably causing the suppression of stress tolerance of *P. infestans* under the melatonin treatment.

###### 

The differentially expressed genes related to stress in transcriptome.

  **Gene_id**                **Log2Foldchange**   **Padj**   **Interpro description**
  -------------------------- -------------------- ---------- ---------------------------------------------------------------
  [PITG_05579](PITG_05579)   0.67299              0.024625   Catalase-peroxidase, putative
  [PITG_10772](PITG_10772)   0.47203              0.026249   Putative GPI-anchored elicitin INL11b-like protein
  [PITG_12561](PITG_12561)   0.8956               0.008554   Elicitin INF2A-like protein
  [PITG_12555](PITG_12555)   1.0902               7.53E-07   Elicitin-like protein, putative
  [PITG_06373](PITG_06373)   0.93318              0.001776   Putative GPI-anchored serine-rich elicitin INL3b-like protein
  [PITG_16907](PITG_16907)   1.5662               4.22E-20   Elicitin-like protein
  [PITG_10284](PITG_10284)   −1.3374              7.98E-11   Cellulose binding elicitor lectin (CBEL), putative
  [PITG_11249](PITG_11249)   −0.90696             7.63E-08   Heat shock 70 kDa protein
  [PITG_05498](PITG_05498)   −0.52905             0.005572   Heat shock protein 90, putative
  [PITG_13826](PITG_13826)   −0.45753             0.02728    Hybrid signal transduction histidine kinase, putative
  [PITG_20715](PITG_20715)   −0.52667             0.008664   Deoxyribodipyrimidine photolyase, putative
  [PITG_11247](PITG_11247)   −0.72089             7.62E-05   Heat shock 70 kDa protein
  [PITG_02805](PITG_02805)   −0.73632             3.88E-05   DNA mismatch repair protein Msh2, putative
  [PITG_22799](PITG_22799)   −1.1375              0.006449   Elicitin-like protein INL3B
  [PITG_04709](PITG_04709)   −0.43251             0.043581   DNA ligase

Differentially expressed genes related to drug resistance of *P. infestans* were affected by melatonin
------------------------------------------------------------------------------------------------------

The transcriptome data also showed that the expression of some DEGs related to drug resistance was also affected by melatonin. The down-regulation of drug resistance genes by melatonin treatment was possibly the reason for the synergistic effects with Infinito. For example, among the 25 most down-regulated differentially expressed genes, there were two genes encoding major facilitator superfamilies (MFS) (Figure [S3](#SM3){ref-type="supplementary-material"}). MFS is regarded as a major mechanism of drug resistance by transporting the drug from the cytoplasm to extracellular space (Kumar et al., [@B40]). The overexpression of MFS can confer the cell with resistant to many toxic compounds, while the mutant of MFS cannot (Morschhauser, [@B53]; Kumar et al., [@B40]). These results suggested that the down-regulation of MFS gene expression could lead to the reduction of the drug resistance of *P. infestans*. Thus, the down-regulated MFS in transcriptome could weaken the drug resistance of *P. infestans*, leading to the synergic effects of melatonin combination with Infinito, such as reducing the use and increasing cytotoxicity of Infinito. Furthermore, consistent with the previous study, melatonin is able to overcome the clofarabine resistance in leukemic cell lines: combination of melatonin and clofarabine significantly increase cytotoxicity in resistant leukemic cell lines (Yamanishi et al., [@B80]).

Differentially expressed genes related to virulence of *P. infestans* were affected by melatonin
------------------------------------------------------------------------------------------------

The transcriptome data also showed that the expression of some DEGs related to virulence was also affected by melatonin. *P. infestans*, like other pathogens, can employ proteins related to virulence to facilitate colonization and infection, such as the apoplastic effectors which are secreted into the plant extracellular, cytoplasmic effectors which are translocated into the plant cell, Cytochrome P450, (Haas et al., [@B33]; Tian et al., [@B76]; Dong et al., [@B20]). Elicitins are apoplastic effectors for helping pathogen invasion into plants in a negative manner (Schornack et al., [@B68]). The reduced expression of elicitins help the pathogen to evade the host innate immunity, and the mutations of elicitin INF1 of *P. infestans* could cause the disease lesions (Kamoun et al., [@B37]; Schornack et al., [@B68]). Our transcriptome data showed that six genes encoding elicitin proteins were up-regulated but two were down-regulated in response to melatonin treatment (Table [7](#T7){ref-type="table"}), suggesting that the virulence of *P. infestans* was reduced by melatonin. Most of these virulence-related proteins likely help pathogen to more access and entry into plants and in causing serious disease, by higher expression, such as: CBEL (apoplastic effector), Crinkler protein (CRN) (more than 200) (cytoplasmic effectors), and many Cytochrome P450 (Beyer et al., [@B9]; Gaulin et al., [@B26]; Haas et al., [@B33]). For example, the CRN protein mutant reduced the virulence of pathogen (Amaro et al., [@B4]). The down-regulated genes encoding CRN, CBEL, and Cytochrome P450 were major in the transcriptome data (Table [7](#T7){ref-type="table"}), indicating that the virulence of *P. infestans* was impaired by melatonin. Thus, deregulation of genes by melatonin associated with the virulence might reduce the virulence of the pathogen invading the host, which could be one of the reasons for the attenuation of potato late blight in our observations.

###### 

The differentially expressed genes related to pathogenesis in transcriptome.

  **Gene_id**                **Log2Foldchange**   **Padj**   **Interpro description**
  -------------------------- -------------------- ---------- ------------------------------------------------------------------------------------------------------------------------
  [PITG_01370](PITG_01370)   −0.6879              0.000424   ATP-binding Cassette (ABC) Superfamily
  [PITG_05987](PITG_05987)   1.199                3.91E-07   ATP-binding Cassette (ABC) superfamily
  [PITG_06852](PITG_06852)   −0.73087             2.83E-05   ATP-binding Cassette (ABC) Superfamily
  [PITG_06860](PITG_06860)   1.2086               0.004669   ATP-binding Cassette (ABC) Superfamily
  [PITG_06862](PITG_06862)   0.99317              0.01237    ATP-binding Cassette (ABC) Superfamily
  [PITG_06863](PITG_06863)   1.038                3.53E-10   ATP-binding Cassette (ABC) Superfamily
  [PITG_07134](PITG_07134)   0.66538              0.000928   ATP-binding Cassette (ABC) Superfamily
  [PITG_07716](PITG_07716)   0.60179              0.00174    ATP-binding Cassette (ABC) Superfamily
  [PITG_07717](PITG_07717)   0.53475              0.00836    ATP-binding Cassette (ABC) Superfamily
  [PITG_11373](PITG_11373)   −0.56642             0.025893   ATP-binding Cassette (ABC) superfamily
  [PITG_13282](PITG_13282)   0.58644              0.007202   ATP-binding Cassette (ABC) Superfamily
  [PITG_13558](PITG_13558)   −0.6312              0.000553   ATP-binding Cassette (ABC) Superfamily
  [PITG_13575](PITG_13575)   0.48026              0.021395   ATP-binding Cassette (ABC) Superfamily
  [PITG_15731](PITG_15731)   0.56494              0.009076   ATP-binding Cassette (ABC) Superfamily
  [PITG_17053](PITG_17053)   0.8252               1.21E-05   ATP-binding Cassette (ABC) Superfamily
  [PITG_20815](PITG_20815)   1.5519               2.82E-21   ATP-binding Cassette (ABC) Superfamily
  [PITG_04809](PITG_04809)   −0.62118             0.006352   Crinkler (CRN) domain, pseudogene
  [PITG_14319](PITG_14319)   −4.8844              0.008491   Crinkler (CRN) family protein
  [PITG_04435](PITG_04435)   −0.54746             0.030686   Crinkler (CRN) family protein
  [PITG_22856](PITG_22856)   −0.66451             0.001265   Crinkler (CRN) family protein
  [PITG_23273](PITG_23273)   −1.3231              3.6E-06    Crinkler (CRN) family protein
  [PITG_14343](PITG_14343)   −0.66068             0.028973   Crinkler (CRN) family protein
  [PITG_16584](PITG_16584)   −0.45693             0.037047   Crinkler (CRN) family protein
  [PITG_16614](PITG_16614)   −0.73791             0.042338   Crinkler (CRN) family protein
  [PITG_16619](PITG_16619)   −0.79746             0.000581   Crinkler (CRN) family protein
  [PITG_18503](PITG_18503)   −0.63181             0.010154   Crinkler (CRN) family protein
  [PITG_19589](PITG_19589)   −0.68915             0.000276   Crinkler (CRN) family protein
  [PITG_20171](PITG_20171)   −0.63579             0.00405    Crinkler (CRN) family protein
  [PITG_22186](PITG_22186)   −0.63536             0.034212   Crinkler (CRN) family protein, pseudogene
  [PITG_03400](PITG_03400)   −0.51195             0.017922   Crinkler (CRN) family protein, putative
  [PITG_04768](PITG_04768)   −0.52386             0.048344   Crinkler (CRN) family protein, putative
  [PITG_17517](PITG_17517)   −0.70149             0.000199   Crinkler (CRN) family protein, putative
  [PITG_07699](PITG_07699)   −1.3195              6.58E-15   Cytochrome P450, putative
  [PITG_14013](PITG_14013)   −0.74111             3.33E-05   Cytochrome P450, putative
  [PITG_14388](PITG_14388)   −0.58475             0.029546   Cytochrome P450, putative
  [PITG_21524](PITG_21524)   0.95041              1.23E-06   Cytochrome P450, putative
  [PITG_12561](PITG_12561)   0.8956               0.008554   Elicitin INF2A-like protein
  [PITG_16907](PITG_16907)   1.5662               4.22E-20   Elicitin-like protein
  [PITG_20414](PITG_20414)   −0.66577             0.001878   Elicitin-like protein
  [PITG_22799](PITG_22799)   −1.1375              0.006449   Elicitin-like protein INL3B
  [PITG_12555](PITG_12555)   1.0902               7.53E-07   Elicitin-like protein, putative
  [PITG_10772](PITG_10772)   0.47203              0.026249   Putative GPI-anchored elicitin INL11b-like protein
  [PITG_20412](PITG_20412)   0.53758              0.010979   Putative GPI-anchored serine rich elicitin SOL13E-like protein
  [PITG_06373](PITG_06373)   0.93318              0.001776   Putative GPI-anchored serine-rich elicitin INL3b-like protein
  [PITG_02830](PITG_02830)   −2.3632              6.03E-28   Secreted RxLR effector peptide protein, putative
  [PITG_15235](PITG_15235)   −2.1923              5.28E-17   Secreted RxLR effector peptide protein, putative
  [PITG_22675](PITG_22675)   0.983                0.012687   Secreted RxLR effector peptide protein, putative
  [PITG_03192](PITG_03192)   2.5813               8.22E-05   Secreted RxLR effector peptide protein, putative
  [PITG_04049](PITG_04049)   1.1756               1.45E-09   Secreted RxLR effector peptide protein, putative
  [PITG_06308](PITG_06308)   1.4386               3.75E-08   Secreted RxLR effector peptide protein, putative
  [PITG_10396](PITG_10396)   −1.0182              0.032769   Secreted RxLR effector peptide protein, putative
  [PITG_10654](PITG_10654)   −0.75283             0.010483   Secreted RxLR effector peptide protein, putative
  [PITG_11947](PITG_11947)   −0.59988             0.040855   Secreted RxLR effector peptide protein, putative
  [PITG_13847](PITG_13847)   0.55452              0.024395   Secreted RxLR effector peptide protein, putative
  [PITG_14884](PITG_14884)   1.0544               0.000997   Secreted RxLR effector peptide protein, putative
  [PITG_23035](PITG_23035)   0.65992              0.001252   Secreted RxLR effector peptide protein, putative
  [PITG_15039](PITG_15039)   0.76481              0.007932   Secreted RxLR effector peptide protein, putative
  [PITG_15125](PITG_15125)   0.89507              0.00824    Secreted RxLR effector peptide protein, putative
  [PITG_16427](PITG_16427)   0.97811              1.08E-05   Secreted RxLR effector peptide protein, putative
  [PITG_23092](PITG_23092)   2.6575               2.54E-11   Secreted RxLR effector peptide protein, putative
  [PITG_17309](PITG_17309)   0.91868              1.44E-05   Secreted RxLR effector peptide protein, putative
  [PITG_17316](PITG_17316)   1.014                7.82E-06   Secreted RxLR effector peptide protein, putative
  [PITG_04085](PITG_04085)   0.6237               0.006739   Avrblb2 family secreted RxLR effector peptide protein, putativeAvrblb2 family secreted RxLR effector peptide, putative
  [PITG_04086](PITG_04086)   0.69051              0.001675   Avrblb2 family secreted RxLR effector peptide protein, putativeAvrblb2 family secreted RxLR effector peptide, putative
  [PITG_20300](PITG_20300)   0.92685              0.002562   Avrblb2 family secreted RxLR effector peptide, putative
  [PITG_10284](PITG_10284)   −1.3374              7.98E-11   Cellulose binding elicitor lectin (CBEL), putative

Differentially expressed genes related to circadian rhythms of *P. infestans* treated by melatonin were not observed
--------------------------------------------------------------------------------------------------------------------

The function of melatonin is well known to regulate circadian rhythms. The circadian rhythms also may regulate the physiological function of fungus, including virulence and mycelia (Liu and Bellpedersen, [@B45]; Brody et al., [@B13]; Hevia et al., [@B36]). Therefore, we investigated whether melatonin altered circadian rhythms-related genes of *P. infestans*. However, the core circadian rhythms genes of fungus, such as FRQ, WC-1,WC-2 (Liu and Bellpedersen, [@B45]; Salichos and Rokas, [@B65]), were not observed in the transcriptome data; the GO terms or KEGG pathway involved in circadian rhythms were also not detected in transcriptome data (Tables [S4](#SM8){ref-type="supplementary-material"}, [S5](#SM9){ref-type="supplementary-material"}). This observation likely caused by the continuous darkness growth condition of *P. infestans* in this study.

Validation of gene expression profiles using RT-qPCR
----------------------------------------------------

To confirm these transcriptome-based observations, nine DEGs encoding rate-limiting enzymes in metabolism, and four DEGs involved in pathogenesis were selected for the real-time PCR (RT-qPCR) based confirmation studies. The results were highly consistent with these in the in transcriptome dataset (Figure [S4](#SM4){ref-type="supplementary-material"}), suggesting that the datasets derived from the transcriptome assay are reliable and valid.

Conclusion {#s4}
==========

In this study, exogenous application of melatonin significantly attenuated the potato late blight by inhibiting mycelial growth, changing cell ultrastructure, reducing the virulence and impairing stress tolerance of *P. infestans*. Importantly, melatonin reduced the doses and enhanced the effects of fungicide for potato late blight control, because of the synergistic inhibitory effects generated by co-treating with melatonin and fungicide. The analysis of the transcriptome suggests that the inhibitory effects of melatonin on *P. infestans* is most likely due to altering the homeostasis of amino acid metabolism. Furthermore, melatonin also altered the expression of important factors associated to stress tolerance, fungicide resistance and virulence. These observations also revealed the direct inhibitory effects of melatonin on the growth of *P. infestans* for the first time and provided new insights into the mechanisms of the direct interaction between melatonin and plant pathogens. Melatonin treatment showed some advantages in for the control of potato late blight in comparison with traditional chemical fungicides and potential application valuable in the cultivation of resistant variety. Firstly, the commonly used chemical fungicides usually display toxicity to humans and animals, whereas melatonin shows less toxicity even under high concentrations. Secondly, as a potential synergist, melatonin has great potential to reduce the use of chemical fungicides. It not only maximizes the efficiency of chemical fungicides and minimizes the use of chemical fungicides, but also reduces fungicide pollution. Additionally, there is potential to develop novel transgenic potato plants which may not only produce more melatonin but also generate the small RNA targeting the key regulators of amino acid metabolism in *P. infestans*, by manipulating the key genes controlling the biogenesis of melatonin in potato and amino acid metabolism in *P. infestans*, respectively.
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**(A)** The lesion size of leaves infected by *P. infestans* treated with DMSO, melatonin, Infinito, melatonin + Infinito, respectively, after 5 days. **(B)** The lesion size of tuber slices treated with DMSO, melatonin, Infinito, melatonin + Infinito, respectively, after 5 days.
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The detail heat-map of total DEGs induced by melatonin.

###### 

Click here for additional data file.

###### 

The top 25 down-regulated genes. 1. Putative uncharacterized protein; 2. Hypothetical protein O9G_005006; 3. Unknown protein; 4.Crinkler (CRN) family protein; 5. Unknown protein; 6. Unknown protein; 7. 12-oxophytodienoate reductase, putative; 8. Putative uncharacterized protein; 9. Putative uncharacterized protein; 10. Unknown protein; 11. Alcohol dehydrogenase, putative; 12. Major Facilitator Superfamily (MFS); 13. Putative uncharacterized protein; 14. Unknown protein; 15. Alcohol dehydrogenase, putative; 16. Secreted RxLR effector peptide protein, putative; 17. Putative uncharacterized protein; 18. Putative uncharacterized protein; 19. Putative uncharacterized protein; 20. Secreted RxLR effector peptide protein, putative; 21. Aquaporin, putative; 22. Major Facilitator Superfamily (MFS); 23. Putative uncharacterized protein; 24. Putative uncharacterized protein; 25. Putative uncharacterized protein.
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###### 

Expression levels of 9 genes encoding rate-limiting enzymes and 4 genes related to pathogenesis in the 3 mM melatonin treatment for 24 h. 1. 6-phosphofructokinase, putative; 2. Pyruvate kinase; 3. Fructose-bisphosphate aldolase; 4. Glycerol-3-phosphate O-acyltransferase, putative; 5. Isocitrate dehydrogenase \[NADP\]; 6. Aconitate hydratase, putative; 7. Acetyl-CoA carboxylase, putative; 8. Glucokinase, putative; 9. Glucokinase, putative; 10. Crinkler (CRN) family protein, putative; 11. Cytochrome P450, putative; 12. Cellulose binding elicitor lectin (CBEL), putative; 13. Elicitin INF2A-like protein.
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